John is the most knowledgeable expert on international early access to innovative drugs that I ever met. He has 20 years of experience with the ever-changing regulations governing early access in multiple countries and helped us set up a reliable and compliant distribution network in record time which changed the lives of patients affected by inherited errors of metabolism in 12 European countries. I am impressed by John’s sense of urgency, his customer orientation and flexibility and would recommend him to anyone seeking advice on this challenging area of business.